Literature DB >> 6181775

Specific targets for antiviral drugs.

E De Clercq.   

Abstract

Mesh：

Substances：

Year:  1982        PMID： 6181775      PMCID： PMC1158439          DOI： 10.1042/bj2050001

Source DB:  PubMed          Journal:  Biochem J        ISSN： 0264-6021            Impact factor:   3.857


× No keyword cloud information.
  73 in total

1.  The broad spectrum antiviral agent ribavirin inhibits capping of mRNA.

Authors:  B B Goswami; E Borek; O K Sharma; J Fujitaki; R A Smith
Journal:  Biochem Biophys Res Commun       Date:  1979-08-13       Impact factor: 3.575

2.  Selective inhibition of the replication of herpes simplex virus by 5-halogenated analogues of deoxycytidine.

Authors:  I Schildkraut; G M Cooper; S Greer
Journal:  Mol Pharmacol       Date:  1975-03       Impact factor: 4.436

3.  Nucleosides. 110. Synthesis and antiherpes virus activity of some 2'-fluoro-2'-deoxyarabinofuranosylpyrimidine nucleosides.

Authors:  K A Watanabe; U Reichman; K Hirota; C Lopez; J J Fox
Journal:  J Med Chem       Date:  1979-01       Impact factor: 7.446

4.  Acyclovir in herpes zoster.

Authors:  N A Peterslund; K Seyer-Hansen; J Ipsen; V Esmann; H Schonheyder; H Juhl
Journal:  Lancet       Date:  1981-10-17       Impact factor: 79.321

5.  Parenteral acyclovir therapy for herpesvirus infections in man.

Authors:  P J Selby; R L Powles; B Janeson; H E Kay; J G Watson; R Thornton; G Morgenstern; H M Clink; T J McElwain; H G Prentice; R Corringharn; M G Ross; A V Hoffbrand; D Brigden
Journal:  Lancet       Date:  1979-12-15       Impact factor: 79.321

6.  (E)-5-(2-Bromovinyl)-2'-deoxyuridine: a potent and selective anti-herpes agent.

Authors:  E De Clercq; J Descamps; P De Somer; P J Barr; A S Jones; R T Walker
Journal:  Proc Natl Acad Sci U S A       Date:  1979-06       Impact factor: 11.205

7.  Antiviral activity of Win 41258-3, a pyrazole compound, against herpes simplex virus in mouse genital infection and in guinea pig skin infection.

Authors:  F Pancic; B A Steinberg; G D Diana; P M Carabateas; W G Gorman; P E Came
Journal:  Antimicrob Agents Chemother       Date:  1981-03       Impact factor: 5.191

8.  Inhibitory effect of 1-beta-D-arabinofuranosylthymine 5'-triphosphate and 1-beta-D-arabinofuranosylcytosine 5'-triphosphate on DNA polymerases from murine cells and oncornavirus.

Authors:  A Matsukage; K Ono; A Ohashi; T Takahashi; C Nakayama; M Saneyoshi
Journal:  Cancer Res       Date:  1978-09       Impact factor: 12.701

9.  On the mechanism of inhibition of influenza virus replication by amantadine hydrochloride.

Authors:  J J Skehel; A J Hay; J A Armstrong
Journal:  J Gen Virol       Date:  1978-01       Impact factor: 3.891

10.  Acyclovir prophylaxis of herpes-simplex-virus infections.

Authors:  R Saral; W H Burns; O L Laskin; G W Santos; P S Lietman
Journal:  N Engl J Med       Date:  1981-07-09       Impact factor: 91.245
View more
  16 in total

1.  Identification and characterization of a varicella-zoster virus DNA-binding protein by using antisera directed against a predicted synthetic oligopeptide.

Authors:  P R Kinchington; G Inchauspe; J H Subak-Sharpe; F Robey; J Hay; W T Ruyechan
Journal:  J Virol       Date:  1988-03       Impact factor: 5.103

Review 2.  Antiviral therapy in AIDS. Clinical pharmacological properties and therapeutic experience to date.

Authors:  E G Sandström; J C Kaplan
Journal:  Drugs       Date:  1987-09       Impact factor: 9.546

3.  Posttranscriptional regulation of a class of human cytomegalovirus phosphoproteins encoded by an early transcription unit.

Authors:  D A Wright; D H Spector
Journal:  J Virol       Date:  1989-07       Impact factor: 5.103

4.  Identification and characterization of a major early cytomegalovirus DNA-binding protein.

Authors:  D G Anders; A Irmiere; W Gibson
Journal:  J Virol       Date:  1986-05       Impact factor: 5.103

Review 5.  Antiviral drugs for AIDS. Current status and future prospects.

Authors:  E Sandström
Journal:  Drugs       Date:  1986-06       Impact factor: 9.546

6.  Mode of action of a new type of UDP-glucose analog against herpesvirus replication.

Authors:  B Alarcón; M E González; L Carrasco; P P Méndez-Castrillón; M T García-López; F G de las Heras
Journal:  Antimicrob Agents Chemother       Date:  1988-08       Impact factor: 5.191

7.  Effect of (E)-5-(2-bromovinyl)-2'-deoxyuridine on synthesis of herpes simplex virus type 1-specific polypeptides.

Authors:  S A Siegel; M J Otto; E De Clercq; W H Prusoff
Journal:  Antimicrob Agents Chemother       Date:  1984-05       Impact factor: 5.191

8.  Inhibition of vaccinia virus growth and virus-specific RNA synthesis by 3'-O-methyl adenosine and 3'-O-methyl guanosine.

Authors:  B B Goswami; O K Sharma
Journal:  J Virol       Date:  1983-03       Impact factor: 5.103

9.  Antiviral effects of hygromycin B, a translation inhibitor nonpermeant to uninfected cells.

Authors:  J C Lacal; L Carrasco
Journal:  Antimicrob Agents Chemother       Date:  1983-08       Impact factor: 5.191

Review 10.  Antiviral therapy in human immunodeficiency virus infection.

Authors:  E Sandström
Journal:  Drugs       Date:  1989-09       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.